Tuberculosis and cancer: A complex and dangerous liaison

The Lancet Oncology

Volumn 12, Issue 6, 2011, Pages 520-522

  Vento, Sandro ^a   Lanzafame, Massimiliano ^b  

^a UNIVERSITY OF BOTSWANA   (Botswana)

^b GB Rossi University Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISONIAZID; TUMOR NECROSIS FACTOR ALPHA;

ASPIRATION BIOPSY; AWARENESS; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; DNA DAMAGE; HAZARD RATIO; HUMAN; LETTER; LUNG CANCER; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; SYMPTOM; TUBERCULIN TEST; TUBERCULOSIS CONTROL;

HUMANS; LUNG NEOPLASMS; NEOPLASMS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79957479613     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70105-X     Document Type: Letter

References (11)

1. Yu YH, Liao CC, Hsu WH, et al. Increased lung cancer risk among patients with pulmonary tuberculosis. A population cohort study. J Thorac Oncol 2011, 6:32-37.
2. Liang HY, Li XL, Yu XS, et al. Facts and fiction of the relationship between pre-existing tuberculosis and lung cancer risk: a systematic review. Int J Cancer 2009, 125:2936-2944.
3. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M Inhibition of NF-kB in cancer cells converts inflammation-induced tumor growth mediated by TNF-α to TRAIL-mediated tumor regression. Cancer Cell 2004, 6:297-305.
4. Hussain SP, Hofseth LJ, Harris CC Radical causes of cancer. Nat Rev Cancer 2003, 3:276-285.
5. Yu YY, Pinsky PF, Caporaso NE, et al. Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostrate, lung, colorectal, and ovarian screening trial. Arch Intern Med 2008, 168:2326-2332.
6. Wu CY, Hu HY, Pu CY, et al. Aerodigestive tract, lung and haematological cancers are risk factors for tuberculosis: an 8-year population-based study. Int J Tuberc Lung Dis 2011, 15:125-130.
7. Richeldi L, Losi M, D'Amico R, et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 2009, 136:198-204.
8. Diel R, Loddenkemper R, Nienhaus A, et al. Evidence-based comparison of commercial interferon-γ release assays for detecting active TB. A metaanalysis. Chest 2010, 137:952-968.
9. Lee SH, Min JW, Lee CH, et al. Impact of parenchymal tuberculosis sequelae on mediastinal lymph node staging in patients with lung cancer. J Korean Med Sci 2011, 26:67-70.
10. Kuo CH, Chen HC, Chung FT, et al. Diagnostic value of EBUS-TBNA for lung cancer with non-enlarged lymph nodes: a study in a tuberculosis-endemic country. PLoS ONE 2011, 6:e16877.
11. Shebl FM, Engels EA, Goedert JJ, Chaturvedi AK Pulmonary infections and risk of lung cancer among persons with AIDS. J Acquir Immune Defic Syndr 2010, 55:375-379.